Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease

被引:27
作者
Ikee, Ryota [1 ,2 ]
Hamasaki, Yoshifumi [1 ,2 ]
Oka, Machiko [1 ,2 ]
Maesato, Kyoko [1 ,2 ]
Mano, Tsutomu [1 ,2 ]
Moriya, Hidekazu [1 ,2 ]
Ohtake, Takayasu [1 ,2 ]
Kobayashi, Shuzo [1 ,2 ]
机构
[1] Shonan Kamakura Gen Hosp, Dept Nephrol, Kanagawa 2478533, Japan
[2] Shonan Kamakura Gen Hosp, Kidney & Dialysis Ctr, Kanagawa 2478533, Japan
来源
NEPHRON CLINICAL PRACTICE | 2008年 / 108卷 / 02期
关键词
chronic kidney disease; hyperglycemia; hyperinsulinemia; insulin resistance; renal pathology;
D O I
10.1159/000115329
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: The relation between insulin resistance and atherosclerosis is widely recognized, but it remains unknown whether glucose metabolism/insulin resistance is related to renal pathology in humans. Methods: We quantitatively evaluated pathological changes in the glomeruli, tubulointerstitium, and vessels in renal biopsy specimens from 23 patients with non-diabetic chronic kidney disease (CKD), all of whom took a 75-gram oral glucose tolerance test. We correlated the renal pathological changes with fasting plasma glucose (FPG), fasting plasma insulin, 2-hour plasma glucose (2-h PG), 2-hour plasma insulin (2-h PI), homeostasis model assessment of insulin resistance (HOMA-IR), and body mass index. Results: HOMA-IR exceeded 1.73 in 11 patients (47.8%), and 2-h PI exceeded 64.0 mu U/ml in 14 (60.9%). FPG significantly correlated with interstitial fibrosis (r = 0.532, p = 0.009). The significance was marginal in the correlation between FPG and tubular atrophy and arterio-arteriolosclerosis. Statistically significant correlation was also found between 2-h PG and arterio-arteriolosclerosis (r = 0.422, p = 0.04) and between HOMA-IR and interstitial fibrosis (r = 0.416, p = 0.04). Conclusion: Although precise mechanisms remain unknown, glucose metabolism/insulin resistance seem to play pathogenic roles in formation and progression of renal pathological changes, especially tubulointerstitial and vascular lesions, in non-diabetic CKD. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:C163 / C168
页数:6
相关论文
共 46 条
[1]
Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance [J].
Anan, F ;
Takahashi, N ;
Ooie, T ;
Hara, M ;
Yoshimatsu, H ;
Saikawa, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (06) :777-781
[2]
Mechanisms of the age-associated deterioration in glucose tolerance - Contribution of alterations in insulin secretion, action, and clearance [J].
Basu, R ;
Breda, E ;
Oberg, AL ;
Powell, CC ;
Dalla Man, C ;
Basu, A ;
Vittone, JL ;
Klee, GG ;
Arora, P ;
Jensen, MD ;
Toffolo, G ;
Cobelli, C ;
Rizza, RA .
DIABETES, 2003, 52 (07) :1738-1748
[3]
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study [J].
Becker, B ;
Kronenberg, F ;
Kielstein, JT ;
Haller, H ;
Morath, C ;
Ritz, E ;
Fliser, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1091-1098
[4]
Borch-Johnsen K, 1999, LANCET, V354, P617
[5]
Podocyte lesions in patients with obesity-related glomerulopathy [J].
Chen, Hui-Mei ;
Liu, Zhi-Hong ;
Zeng, Cai-Hong ;
Li, Shi-Jun ;
Wang, Qing-Wen ;
Li, Lei-Shi .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (05) :772-779
[6]
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[7]
INSULIN RESISTANCE IN UREMIA [J].
DEFRONZO, RA ;
ALVESTRAND, A ;
SMITH, D ;
HENDLER, R ;
HENDLER, E ;
WAHREN, J .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (02) :563-568
[8]
THE PREVALENCE OF INSULIN-RESISTANCE IN KIDNEY-DISEASE PATIENTS BEFORE THE DEVELOPMENT OF RENAL-FAILURE [J].
DZURIK, R ;
SPUSTOVA, V ;
JANEKOVA, K .
NEPHRON, 1995, 69 (03) :281-285
[9]
Fort J, 2005, KIDNEY INT, V68, P25
[10]
Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia [J].
Fujiwara, T ;
Saitoh, S ;
Takagi, S ;
Takeuchi, H ;
Isobe, T ;
Chiba, Y ;
Miura, T ;
Shimamoto, K .
HYPERTENSION RESEARCH, 2005, 28 (08) :665-670